Safety Alerts & Recalls

Alerts for Ezetimibe with Simvastatin

Title Date Published Source
Healthcare Professionals Given Latest Summary of Benefits and Risks of Statins 2014-06-06
Drug Induce Liver Injury Poses Challenge for Health Professionals 2013-10-04
New Study Links Statins to a Small Increase in the Risk of Muscle Disease or Injury 2013-06-06
Study Suggests Some Statin Drugs Increase Older Patients’ Risk of Diabetes 2013-05-29
MHRA Publishes Patient Article on Recent Simvastatin Dose Changes 2012-10-30
Healthcare Professionals Informed of Updated Interaction Advice for Simvastatin 2012-08-24
TGA Issues Statement about Statin Safety Review 2012-03-03
TGA Reviewing Safety of Statins 2012-03-01
FDA Provides Safety Advice for Statins 2012-02-28
Las Estatinas Relacionadas Con Un Aumento De Azúcar En Sangre Y Diabetes En Algunos Pacientes 2012-01-27
Statins Linked to Raised Blood Sugar and Diabetes in Some Patients 2012-01-16
FDA Revises Dose Limitation for Zocor (simvastatin) When Taken with Amiodarone 2011-12-15
TGA Recommends Dose Limits for Simvastatin 2011-12-05
Neue Studie legt das Auftreten von Diabetes durch Behandlung mit Statinen nahe 2011-07-07
Une nouvelle étude suggère que les statines à dose élevée peuvent causer un diabète 2011-07-06
Un Nuevo Estudio Propone Que Dosis Altas De Estatinas Pueden Causar Diabetes 2011-07-05
New Study Suggests High-Dose Statins May Cause Diabetes 2011-06-29
New Study Suggests High-Dose Statins May Cause Diabetes 2011-06-23
FDA Limits Use of 80 mg Simvastatin 2011-06-08
Product Information For Simvastatin (Zocor) and Simvastatin Combined With Ezetimibe (Inegy) Warns About Risks of Muscle Pain and Weakness 2010-06-08
FDA: Ongoing Safety Review of High-Dose Simvastatin (Zocor) and Increased Risk of Muscle Injury 2010-03-19
Statin Benefits Still Outweigh New Safety Information 2010-02-17
Follow-up to the FDA's Ongoing Safety Review of Ezetimibe/Simvastatin (marketed as Vytorin), Simvastatin (marketed as Zocor) and Ezetimibe (marketed as Zetia) 2009-12-23
FDA Issues Final Review of ENHANCE Study 2009-01-09
FDA Is Reviewing Results From a Recent Clinical Trial of Vytorin 2008-08-22
Combination use can lead to rare condition of muscle damage 2008-08-08
Preliminary results from the SEAS trial 2008-07-23
Early communication regarding ongoing FDA review 2008-01-27
See alerts for all drugs
Share your story Share your story! Tell us how MediGuard has helped you or someone you love. Mobile graphic Download the MediGuard Mobile App to manage your prescription and over-the-counter medications, for free. Registration Info Taking multiple medications puts you at risk for possible drug-drug interactions Registration Info Monitor the medical treatment of you and your loved ones.